Претрага

Резултати

Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid. [2024]

Zahm, Shelia; Bonde, Jens Peter; Chiu, Weihsueh A; Hoppin, Jane; Kanno, Jun; Abdallah, Mohamed; Blystone, Chad R; Calkins, Miriam M; Dong, Guang-Hui; Dorman, David C;

Fry, Rebecca; Guo, Huan; Haug, Line S; Hofmann, Jonathan N; Iwasaki, Motoki; Machala, Miroslav; Mancini, Francesca R; Maria-Engler, Silvya S; Møller, Peter; Ng, Jack C; Pallardy, Marc; Post, Gloria B; Salihovic, Samira; Schlezinger, Jennifer; Soshilov, Anatoly; Steenland, Kyle; Steffensen, Inger-Lise; Tryndyak, Volodymyr; White, Alexandra; Woskie, Susan; Fletcher, Tony; Ahmadi, Ayat; Ahmadi, Nahid; Benbrahim-Tallaa, Lamia; Bijoux, Wendy; Chittiboyina, Shirisha; de Conti, Aline; Facchin, Caterina; Madia, Federica; Mattock, Heidi; Merdas, Mira; Pasqual, Elisa; Suonio, Eero; Viegas, Susana; Zupunski, Ljubica ; Wedekind, Roland; Schubauer-Berigan, Mary K;

Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study [2023]

Leal, Ticiana A; ...; Andric, Zoran G ; ...; (broj, koautora 25)

Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network [2023]

Ludwig, Heinz; ...; Bila, Jelena S. ; ...; (broj koautora 29)

Efficacy and safety of ABP 980 compared with reference trastuzumab in women with HER2-positive early breast cancer (LILAC study): a randomised, double-blind, phase 3 trial [2018]

von, Minckwitz Gunter; Colleoni, Marco A; Kolberg, Hans-Christian; Morales, Serafin; Santi, Patricia Xavier; Tomasevic, Zorica I ; Zhang, Nan; Hanes, Vladimir

Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial [2021]

Dimopoulos, Meletios Athanasios; ...; Bila, Jelena S. ; ...; (broj koautora 23)

Neoadjuvant or perioperative therapy for melanoma metastasis in clinical practice: an international survey [2025]

Hauschild, Axel; ...; Kandolf, Lidija O; ...; (broj, koautora 29)

Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial [2017]

Ferolla, Piero; ...; Stankovic, Miona; ...; (broj, koautora 22)

Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023 [2026]

Bhangdia, Kayleigh; ...; Ilić, Irena M. ; Ilić, Milena D. ; ...; Jakovljević, Mihajlo ; ...; Šantrić-Milićević, Milena M. ; ...; (broj koautora 1019)

Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study [2022]

Cho, Byoung Chul; ...; Secen, Nevena M; ...; (broj, koautora 19)

Melanoma of the small intestine [2009]

Lens, Marko; Bataille, Veronique; Krivokapić, Zoran